NO20003099L - Proteiner for kreftcellespesifikk induksjon av apoptosis, og fremgangsmÕte til isolering derav - Google Patents

Proteiner for kreftcellespesifikk induksjon av apoptosis, og fremgangsmÕte til isolering derav

Info

Publication number: NO20003099L
Authority: NO; Norway
Prior art keywords: cells; cancer; apogen; effect; proteins
Prior art date: 1997-12-18

Application number

NO20003099A

Other languages

English (en)

Norwegian (no)

Other versions

NO20003099D0 (no

Inventor

David Tsai

Jenny Yu

Original Assignee

David Tsai

Jenny Yu

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-18

Filing date

2000-06-16

Publication date

2000-08-17

2000-06-16 Application filed by David Tsai, Jenny Yu filed Critical David Tsai

2000-06-16 Publication of NO20003099D0 publication Critical patent/NO20003099D0/no

2000-08-17 Publication of NO20003099L publication Critical patent/NO20003099L/no

Links

102000004169 proteins and genes Human genes 0.000 title abstract 6
108090000623 proteins and genes Proteins 0.000 title abstract 6
206010028980 Neoplasm Diseases 0.000 title abstract 3
201000011510 cancer Diseases 0.000 title abstract 2
238000000034 method Methods 0.000 title abstract 2
230000006882 induction of apoptosis Effects 0.000 title 1
238000002955 isolation Methods 0.000 title 1
210000004027 cell Anatomy 0.000 abstract 16
RDEIXVOBVLKYNT-VQBXQJRRSA-N (2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(1-aminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol;(2r,3r,4r,5r)-2-[(1s,2s,3r,4s,6r)-4,6-diamino-3-[(2r,3r,6s)-3-amino-6-(aminomethyl)oxan-2-yl]o Chemical compound OS(O)(=O)=O.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@@H](CN)O2)N)[C@@H](N)C[C@H]1N.O1C[C@@](O)(C)[C@H](NC)[C@@H](O)[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@@H](CC[C@H](O2)C(C)N)N)[C@@H](N)C[C@H]1N.O1[C@H](C(C)NC)CC[C@@H](N)[C@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](NC)[C@@](C)(O)CO2)O)[C@H](N)C[C@@H]1N RDEIXVOBVLKYNT-VQBXQJRRSA-N 0.000 abstract 6
206010006187 Breast cancer Diseases 0.000 abstract 6
208000026310 Breast neoplasm Diseases 0.000 abstract 6
206010060862 Prostate cancer Diseases 0.000 abstract 5
208000000236 Prostatic Neoplasms Diseases 0.000 abstract 5
230000006907 apoptotic process Effects 0.000 abstract 5
230000000694 effects Effects 0.000 abstract 5
239000003636 conditioned culture medium Substances 0.000 abstract 4
210000002950 fibroblast Anatomy 0.000 abstract 4
208000032839 leukemia Diseases 0.000 abstract 4
210000004072 lung Anatomy 0.000 abstract 4
201000002313 intestinal cancer Diseases 0.000 abstract 3
201000003741 Gastrointestinal carcinoma Diseases 0.000 abstract 2
230000001939 inductive effect Effects 0.000 abstract 2
208000005016 Intestinal Neoplasms Diseases 0.000 abstract 1
239000002246 antineoplastic agent Substances 0.000 abstract 1
229940041181 antineoplastic drug Drugs 0.000 abstract 1
238000003782 apoptosis assay Methods 0.000 abstract 1
210000004748 cultured cell Anatomy 0.000 abstract 1
230000005522 programmed cell death Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4747—Apoptosis related proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
Genetics & Genomics (AREA)
Toxicology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biochemistry (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Cell Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO20003099A 1997-12-18 2000-06-16 Proteiner for kreftcellespesifikk induksjon av apoptosis, og fremgangsmÕte til isolering derav NO20003099L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US99343297A	1997-12-18	1997-12-18
PCT/US1998/027108 WO1999031135A1 (fr)	1997-12-18	1998-12-18	Proteines destinees a provoquer l'apoptose specifique de cellules cancereuses et procede pour isoler ces proteines

Publications (2)

Publication Number	Publication Date
NO20003099D0 NO20003099D0 (no)	2000-06-16
NO20003099L true NO20003099L (no)	2000-08-17

Family

ID=25539541

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20003099A NO20003099L (no)	1997-12-18	2000-06-16	Proteiner for kreftcellespesifikk induksjon av apoptosis, og fremgangsmÕte til isolering derav

Country Status (11)

Country	Link
EP (1)	EP1037919A1 (fr)
JP (1)	JP2002516821A (fr)
KR (1)	KR20010033260A (fr)
CN (1)	CN1314914A (fr)
AU (1)	AU1933099A (fr)
CA (1)	CA2325368A1 (fr)
IL (1)	IL136850A0 (fr)
MX (1)	MXPA00005954A (fr)
NO (1)	NO20003099L (fr)
PL (1)	PL343247A1 (fr)
WO (1)	WO1999031135A1 (fr)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1997031107A2 (fr) *	1996-02-20	1997-08-28	Coles John G	Apoptose induite par des lectines de serum humain et procede de detection d'apoptose

1998
- 1998-12-18 EP EP98964142A patent/EP1037919A1/fr not_active Withdrawn
- 1998-12-18 JP JP2000539058A patent/JP2002516821A/ja active Pending
- 1998-12-18 IL IL13685098A patent/IL136850A0/xx unknown
- 1998-12-18 PL PL98343247A patent/PL343247A1/xx unknown
- 1998-12-18 CA CA002325368A patent/CA2325368A1/fr not_active Abandoned
- 1998-12-18 KR KR1020007006696A patent/KR20010033260A/ko not_active Withdrawn
- 1998-12-18 AU AU19330/99A patent/AU1933099A/en not_active Abandoned
- 1998-12-18 MX MXPA00005954A patent/MXPA00005954A/es unknown
- 1998-12-18 CN CN98813660A patent/CN1314914A/zh active Pending
- 1998-12-18 WO PCT/US1998/027108 patent/WO1999031135A1/fr not_active Application Discontinuation
2000
- 2000-06-16 NO NO20003099A patent/NO20003099L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
IL136850A0 (en)	2001-06-14
CA2325368A1 (fr)	1999-06-24
PL343247A1 (en)	2001-07-30
WO1999031135A1 (fr)	1999-06-24
AU1933099A (en)	1999-07-05
EP1037919A1 (fr)	2000-09-27
MXPA00005954A (es)	2002-09-18
CN1314914A (zh)	2001-09-26
NO20003099D0 (no)	2000-06-16
JP2002516821A (ja)	2002-06-11
KR20010033260A (ko)	2001-04-25

Similar Documents

Publication	Publication Date	Title
Senger et al.	1983	Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid
Fotsis et al.	1997	Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis
Medina et al.	1998	Sodium butyrate inhibits carcinoma development in a 1, 2‐dimethylhydrazine‐induced rat colon cancer
Coradini et al.	2000	Sodium butyrate modulates cell cycle‐related proteins in HT29 human colonic adenocarcinoma cells
Hrushesky et al.	1988	Natural killer cell activity: age, estrous-and circadian-stage dependence and inverse correlation with metastatic potential
DE69731213D1 (de)	2004-11-18	2-methoxyestradiol-induzierte apoptosis in krebszellen
Slamon	1990	Studies of the HER-2/neu proto-oncogene in human breast cancer
DK0833834T3 (da)	2000-07-31	DNA-sekvens og kodet mamma-specifikt brystcancerprotein
DK0961780T3 (da)	2007-08-27	Proteinmarkörer for lungecancer og anvendelse deraf
NZ512247A (en)	2004-01-30	Compositions and methods for therapy and diagnosis of ovarian cancer
Hua et al.	2020	Antitumor effects of flavokawain-B flavonoid in gemcitabine-resistant lung cancer cells are mediated via mitochondrial-mediated apoptosis, ROS production, cell migration and cell invasion inhibition and blocking of PI3K/AKT Signaling pathway
Cheng et al.	2020	Markers of malignant prostate cancer cells: Golgi localization of α-mannosidase 1A at GM130-GRASP65 site and appearance of high mannose N-glycans on cell surface
BG101875A (en)	1998-10-30	New cryptoficins and method for their preparation
Liang et al.	2022	Apigenin inhibits migration and induces apoptosis of human endometrial carcinoma Ishikawa cells via PI3K-AKT-GSK-3β pathway and endoplasmic reticulum stress
Salimi et al.	2012	Change in nicotine-induced VEGF, PGE 2 AND COX-2 expression following COX inhibition in human oral squamous cancer
NZ524936A (en)	2005-08-26	Methods of inducing cancer cell death and tumor regression using a FTP inhibitor and a tyrosine kinase inhibitor
NO20003099L (no)	2000-08-17	Proteiner for kreftcellespesifikk induksjon av apoptosis, og fremgangsmÕte til isolering derav
Yan et al.	2023	Role of cancer-associated fibroblasts in colorectal cancer and their potential as therapeutic targets
Reed	2002	Keeping p27kip1 in the cytoplasm: a second front in cancer's war on p27
Longaker et al.	1990	Hyaluronic acid-stimulating activity in the pathophysiology of Wilms' tumors
Guruvayoorappan et al.	2008	13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation.
NO20020666D0 (no)	2002-02-11	Anvendelse av ginkgo-ekstrakt
Hossaka et al.	2013	Detection of galectins during malignant transformation of oral cells
Kong et al.	2021	Deoxidized gulose moiety attenuates the pulmonary toxicity of 6'-deoxy-bleomycin Z without effect on its antitumor activity
Kalaivani et al.	2022	Antimelanogenic and Anticancer Activity of Isorhamnetin isolated from Acalypha indica Linn. on A375 cell line.

Legal Events

Date	Code	Title	Description
2003-09-22	FC2A	Withdrawal, rejection or dismissal of laid open patent application